Supported the development of the go-to-market strategy for a multi-billion global pharma player in a Southeast Asia market. Launched initiatives that are anticipated to double the growth rate of the company from 2018 to 2025.
Took ownership and executed modules, including work with high-profile clients, and praised for good analytical rigor by BCG standards.
